Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study

This study has been completed.
Sponsor:
Collaborator:
Sanofi
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01038011
First received: December 15, 2009
Last updated: May 3, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2006
  Primary Completion Date: No date given